A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
A 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression
Inclusion Criteria:
Exclusion Criteria:
Maitland, California 32751, United States
San Diego, California 92102, United States
Rosewekk, Georgia 30076, United States
Brno - Mesto, 602 00, Czechia
Lovosicka, Czechia
Vijaywada, Andh Prad 520002, India
Delhi, National Capital Territory of Delhi 110092, India
Gujarat, 362002, India
Gujarat, 380006, India
Hachioji-shi, 192-0153, Japan
Ichikawa-sha, 272-8516, Japan
Kanzaki-gun, 842-0192, Japan
Kodaira-shi, 187-8551, Japan
Takatsuki-shi, 569-1041, Japan
Bojnice, 92701, Slovakia
Bratislava, 82606, Slovakia
Liptovský Mikuláš, 03123, Slovakia
Kviv, 02660, Ukraine
Lviv, 79021, Ukraine
Ternopil, 46020, Ukraine
Vinnitsia, 21018, Ukraine